Neurocrine Biosciences Stock In The News
| NBIX Stock | USD 139.02 4.17 2.91% |
The overall news coverage of Neurocrine Biosciences from major news outlets shows bullish sentiment on 23 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of Neurocrine Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Neurocrine Biosciences. The specific impact of Neurocrine Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Neurocrine Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Neurocrine Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Neurocrine Biosciences Backtesting and Neurocrine Biosciences Hype Analysis. For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.
Neurocrine |
Neurocrine Biosciences Today Top News and Investor Outlook
Neurocrine Biosciences Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Neurocrine and other traded companies coverage. We help investors stay connected with Neurocrine headlines for the 9th of May to make an informed investment decision based on correlating the impacts of news items on Neurocrine Stock performance. Please note that trading solely based on the Neurocrine Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.Neurocrine Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Neurocrine earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Neurocrine Biosciences that are available to investors today. That information is available publicly through Neurocrine media outlets and privately through word of mouth or via Neurocrine internal channels. However, regardless of the origin, that massive amount of Neurocrine data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Neurocrine Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neurocrine Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neurocrine Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neurocrine Biosciences alpha.
Neurocrine Largest EPS Surprises
Earnings surprises can significantly impact Neurocrine Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2010-10-28 | 2010-09-30 | 0.05 | 0.06 | 0.01 | 20 | ||
1997-10-31 | 1997-09-30 | 0.05 | 0.06 | 0.01 | 20 | ||
2014-04-30 | 2014-03-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2012-07-31 | 2012-06-30 | -0.03 | -0.01 | 0.02 | 66 | ||
2011-07-28 | 2011-06-30 | 0.06 | 0.04 | -0.02 | 33 | ||
2013-10-29 | 2013-09-30 | -0.2 | -0.17 | 0.03 | 15 |
Neurocrine Biosciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Neurocrine Biosciences Stock. The global stock market is bullish. About 63% of major world exchanges and indexes are currently up. See today's market update for more information.
7th of May 2024
Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference at finance.yahoo.com
2nd of May 2024
Neurocrine Biosciences Inc Q1 2024 Earnings Strong Revenue Growth and Strategic Advancemen... at gurufocus.com
1st of May 2024
No. 1 Biotech Stock Neurocrine Pops After Its Biggest Moneymaker Snatches Another Win at investors.com
30th of April 2024
Curious about Neurocrine Q1 Performance Explore Wall Street Estimates for Key Metrics at zacks.com
25th of April 2024
Zoetis Earnings Expected to Grow What to Know Ahead of Next Weeks Release at finance.yahoo.com
17th of April 2024
Neurocrine Biosciences exec sells over 2.6m in stock at investing.com
21st of March 2024
Stock Rally Keeps Going With Dow, SP 500 At New Highs Micron Soars After Big Surprise at investors.com
8th of March 2024
Kennedy Capital Management LLC Sells 5,094 Shares of Neurocrine Biosciences, Inc. at thelincolnianonline.com
Neurocrine Biosciences Investors Sentiment
The influence of Neurocrine Biosciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Neurocrine. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Neurocrine Biosciences' public news can be used to forecast risks associated with an investment in Neurocrine. The trend in average sentiment can be used to explain how an investor holding Neurocrine can time the market purely based on public headlines and social activities around Neurocrine Biosciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Neurocrine Biosciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Neurocrine Biosciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Neurocrine Biosciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Neurocrine Biosciences.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Neurocrine Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Neurocrine Biosciences' short interest history, or implied volatility extrapolated from Neurocrine Biosciences options trading.
Check out Neurocrine Biosciences Backtesting and Neurocrine Biosciences Hype Analysis. For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Neurocrine Stock analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Neurocrine Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurocrine Biosciences. If investors know Neurocrine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurocrine Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.648 | Earnings Share 3.68 | Revenue Per Share 20.147 | Quarterly Revenue Growth 0.226 | Return On Assets 0.1008 |
The market value of Neurocrine Biosciences is measured differently than its book value, which is the value of Neurocrine that is recorded on the company's balance sheet. Investors also form their own opinion of Neurocrine Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Neurocrine Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurocrine Biosciences' market value can be influenced by many factors that don't directly affect Neurocrine Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurocrine Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurocrine Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurocrine Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.